129 related articles for article (PubMed ID: 24738933)
1. The effect of vitamin B1 on bleeding and spotting in women using an intrauterine device: a double-blind randomised controlled trial.
Jafari A; Abedi P; Sayahi M; Torkashvand R
Eur J Contracept Reprod Health Care; 2014 Jun; 19(3):180-6. PubMed ID: 24738933
[TBL] [Abstract][Full Text] [Related]
2. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Wildemeersch D; Schacht E
Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454
[TBL] [Abstract][Full Text] [Related]
3. [Management of abnormal bleeding in an intrauterine device user].
Desmons F; Adam-steen C
Cah Sexol Clin; 1985; 11(63):185-7. PubMed ID: 12281357
[TBL] [Abstract][Full Text] [Related]
4. Treatment of bleeding irregularities in women with copper-containing IUDs: a systematic review.
Godfrey EM; Folger SG; Jeng G; Jamieson DJ; Curtis KM
Contraception; 2013 May; 87(5):549-66. PubMed ID: 23199413
[TBL] [Abstract][Full Text] [Related]
5. [Treatment by tranexamic acid in menorrhagia in women using intrauterine devices].
Bengtsson LP; Weström L
Lakartidningen; 1971 Aug; 68(33):3685-91. PubMed ID: 5129410
[TBL] [Abstract][Full Text] [Related]
6. [Calcium lonazolac and blood loss in users of intrauterine devices. Preliminary report].
Rubio Lotvin B; Ruíz Moreno JA; González Ansorena R; Ibarrola E; Uranga G; Benítez E
Ginecol Obstet Mex; 1986 Aug; 54():221-4. PubMed ID: 3781294
[TBL] [Abstract][Full Text] [Related]
7. Comparison between two IUDs: Progestasert and CuT 200.
Larsen S; Hansen MK; Jacobsen JC; Ladehoff P; Sorensen T; Westergaard JG
Contracept Deliv Syst; 1981 Oct; 2(4):281-6. PubMed ID: 12336988
[TBL] [Abstract][Full Text] [Related]
8. Treatment of increased menstrual blood loss in IUD users.
Toppozada M
Contraception; 1987 Jul; 36(1):145-57. PubMed ID: 3311623
[TBL] [Abstract][Full Text] [Related]
9. Effect of baseline menstrual bleeding pattern on copper intrauterine device continuation.
Hobby JH; Zhao Q; Peipert JF
Am J Obstet Gynecol; 2018 Nov; 219(5):465.e1-465.e5. PubMed ID: 30170037
[TBL] [Abstract][Full Text] [Related]
10. Intrauterine devices. The optimal long-term contraceptive method?
Fortney JA; Feldblum PJ; Raymond EG
J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of etamsylate in intrauterine-device menorrhagia.
Kovács L; Annus J
Gynecol Invest; 1978; 9(4):161-5. PubMed ID: 374202
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of the efficacy of a venotonic capillary protector in the treatment of metrorrhagia due to IUD or micropill contraception].
Monteil-seurin J; Bernard-fernier MF; Martinaggi P; Demarez JP; Cauquil J; Lafont A
Contracept Fertil Sex (Paris); 1985 May; 13(5):721-5. PubMed ID: 12267101
[TBL] [Abstract][Full Text] [Related]
13. IUD-induced uterine bleeding.
El-badrawi HH; Hafez ES
Contracept Deliv Syst; 1980 Oct; 1(4):303-18. PubMed ID: 12262133
[TBL] [Abstract][Full Text] [Related]
14. Action of a prostaglandin synthetase inhibitor on IUD associated uterine bleeding.
Di Lieto A; Catalano D; Miranda L; Paladini A
Clin Exp Obstet Gynecol; 1987; 14(1):41-4. PubMed ID: 3102127
[TBL] [Abstract][Full Text] [Related]
15. Oral micronised flavonoids versus tranexamic acid for treatment of heavy menstrual bleeding secondary to copper IUD use: a randomised double-blind clinical trial.
Alanwar A; Abbas AM; Hussain SH; Elhawwary G; Mansour DY; Faisal MM; Elshabrawy A; Eltaieb E
Eur J Contracept Reprod Health Care; 2018 Oct; 23(5):365-370. PubMed ID: 30247074
[TBL] [Abstract][Full Text] [Related]
16. Preventive treatment of intrauterine device-induced menstrual blood loss with tranexamic acid in Chinese women.
Lin X; Gao ES; Li D; Zhang M; Dou LX; Yuan W
Acta Obstet Gynecol Scand; 2007; 86(9):1126-9. PubMed ID: 17712656
[TBL] [Abstract][Full Text] [Related]
17. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
18. Vitamin E (alpha tocopherol) in the management of menorrhagia associated with the use of intrauterine contraceptive devices (IUCD).
Dasgupta PR; Dutta S; Banerjee P; Majumdar S
Int J Fertil; 1983; 28(1):55-6. PubMed ID: 6134690
[TBL] [Abstract][Full Text] [Related]
19. Menstrual bleeding pattern and iron status in women fitted with copper and non-medicated intrauterine contraceptive devices.
Oyelola OO; Okonofua FE; Adediran TO
East Afr Med J; 1994 Apr; 71(4):268-70. PubMed ID: 8062778
[TBL] [Abstract][Full Text] [Related]
20. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas.
Magalhães J; Aldrighi JM; de Lima GR
Contraception; 2007 Mar; 75(3):193-8. PubMed ID: 17303488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
